Dublin, May 01, 2017 -- Research and Markets has announced the addition of Jain PharmaBiotech's new report "Animal Biotechnology - Technologies, Markets and Companies" to their offering.
This report describes and evaluates animal biotechnology and its application in veterinary medicine and pharmaceuticals as well as improvement in food production. Knowledge of animal genetics is important in the application of biotechnology to manage genetic disorders and improve animal breeding. Genomics, proteomics and bioinformatics are also being applied to animal biotechnology.
Transgenic technologies are used for improving milk production and the meat in farm animals as well as for creating models of human diseases. Transgenic animals are used for the production of proteins for human medical use. Biotechnology is applied to facilitate xenotransplantation from animals to humans. Genetic engineering is done in farm animals and nuclear transfer technology has become an important and preferred method for cloning animals.There is discussion of in vitro meat production by culture
Biotechnology has potential applications in the management of several animal diseases such as foot-and-mouth disease, classical swine fever, avian flu and bovine spongiform encephalopathy. The most important biotechnology-based products consist of vaccines, particularly genetically engineered or DNA vaccines. Gene therapy for diseases of pet animals is a fast developing area because many of the technologies used in clinical trials humans were developed in animals and many of the diseases of cats and dogs are similar to those in humans.RNA interference technology is now being applied for research in veterinary medicine
Molecular diagnosis is assuming an important place in veterinary practice. Polymerase chain reaction and its modifications are considered to be important. Fluorescent in situ hybridization and enzyme-linked immunosorbent assays are also widely used. Newer biochip-based technologies and biosensors are also finding their way in veterinary diagnostics.
Biotechnology products are approved by the Center for Veterinary Medicine of the FDA. Regulatory issues relevant to animal biotechnology are described.
Approximately 124 companies have been identified to be involved in animal biotechnology and are profiled in the report. These are a mix of animal healthcare companies and biotechnology companies. Top companies in this area are identified and ranked. Information is given about the research activities of 11 veterinary and livestock research institutes. Important 108 collaborations in this area are shown.
Share of biotechnology-based products and services in 2016 is analyzed and the market is projected to 2026.
Key Topics Covered:
Executive Summary
1. Introduction to Animal Biotechnology
2. Application of Biotechnology in Animals
3. A Biotechnology Perspective of Animals Diseases
4. Molecular Diagnostics in Animals
5. Biotechnology-based Veterinary Medicine
6. Research in Animal Biotechnology
7. Animal Biotechnology Markets
8. Regulatory issues
9. Companies Involved in Animal Biotechnology
10. References
For more information about this report visit http://www.researchandmarkets.com/research/6hlgn5/animal
Source: Jain PharmaBiotech
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biotechnology


Toyota Raises FY2027 Outlook, Announces ¥1 Trillion Buyback Despite Q1 Profit Dip
BHP Port Hedland Strike Set to Proceed as Wage Talks Continue
SK Hynix Bonus Dispute Deepens as Union Rejects Stock-Based Payout Proposal
BYD July Global Vehicle Sales Rise 22% as Overseas Demand Surges
Bayer Q2 Earnings Beat Forecasts as Crop Science Boosts Results, Debt Outlook Improves
Boeing Stock Jumps as FAA Certifies 737 MAX-7 After Years of Regulatory Review
Warner Bros. Discovery Shares Rise as Newsom Pushes Settlement in $110 Billion Merger Fight
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
Palantir Stock Soars as AI Demand Drives Strong Q2 Earnings and Higher 2026 Outlook
Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand
T-Mobile Executives Reportedly Oppose $300 Billion Deutsche Telekom Merger
Vast Eyes Hong Kong IPO as Chinese AI Unicorn Gains Momentum
Meta Cuts Wipro Outsourcing by 25% After AI-Led Restructuring
Trump Urges Exxon, Chevron to Cut Gas Prices After Record Oil Profits
Prysmian Nears Deal to Acquire Atkore in Potential All-Cash Takeover
Capital One Says AML Review Led to Closure of Trump Organization Accounts 



